BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7706936)

  • 1. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
    Minnich A; Kessling A; Roy M; Giry C; DeLangavant G; Lavigne J; Lussier-Cacan S; Davignon J
    J Lipid Res; 1995 Jan; 36(1):117-24. PubMed ID: 7706936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein lipase gene mutations in coronary artery disease.
    Minnich A; Baloukas J; Roederer G; Lussier-Cacan S; Davignon J; Genest J
    Can J Cardiol; 1998 May; 14(5):711-6. PubMed ID: 9627528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
    Marcil M; Boucher B; Gagné E; Davignon J; Hayden M; Genest J
    J Lipid Res; 1996 Feb; 37(2):309-19. PubMed ID: 9026529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
    Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
    Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
    Syvänne M; Antikainen M; Ehnholm S; Tenkanen H; Lahdenperä S; Ehnholm C; Taskinen MR
    J Lipid Res; 1996 Apr; 37(4):727-38. PubMed ID: 8732773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.
    Evans D; Arzer J; Aberle J; Beil FU
    Atherosclerosis; 2011 Feb; 214(2):386-90. PubMed ID: 21159338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
    Elbein SC; Yeager C; Kwong LK; Lingam A; Inoue I; Lalouel JM; Wilson DE
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1450-6. PubMed ID: 7962342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
    Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
    J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
    Julien P; Vohl MC; Gaudet D; Gagné C; Lévesque G; Després JP; Cadelis F; Brun LD; Nadeau A; Ven Murthy MR
    Diabetes; 1997 Dec; 46(12):2063-8. PubMed ID: 9392497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency.
    Bijvoet S; Gagné SE; Moorjani S; Gagné C; Henderson HE; Fruchart JC; Dallongeville J; Alaupovic P; Prins M; Kastelein JJ; Hayden MR
    J Lipid Res; 1996 Mar; 37(3):640-50. PubMed ID: 8728325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
    Ishimura-Oka K; Semenkovich CF; Faustinella F; Goldberg IJ; Shachter N; Smith LC; Coleman T; Hide WA; Brown WV; Oka K
    J Lipid Res; 1992 May; 33(5):745-54. PubMed ID: 1619366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
    Weinstock PH; Bisgaier CL; Aalto-Setälä K; Radner H; Ramakrishnan R; Levak-Frank S; Essenburg AD; Zechner R; Breslow JL
    J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250-->Asn; Ser251-->Cys) resulting in lipoprotein lipase (LPL) deficiency.
    Bijvoet SM; Wiebusch H; Ma Y; Reymer PW; Bruin T; Bakker HD; Funke H; Assmann G; Hayden MR; Kastelein JJ
    Neth J Med; 1996 Nov; 49(5):189-95. PubMed ID: 8973094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
    Takagi A; Ikeda Y; Mori A; Tsutsumi Z; Oida K; Nakai T; Yamamoto A
    J Lipid Res; 1994 Nov; 35(11):2008-18. PubMed ID: 7868979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23.
    Hölzl B; Kraft HG; Wiebusch H; Sandhofer A; Patsch J; Sandhofer F; Paulweber B
    J Lipid Res; 2000 May; 41(5):734-41. PubMed ID: 10787434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis.
    Chang YT; Chang MC; Su TC; Liang PC; Su YN; Kuo CH; Wei SC; Wong JM
    J Clin Gastroenterol; 2009 Jul; 43(6):591-6. PubMed ID: 19034041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
    García-Otín AL; Civeira F; Peinado-Onsurbe J; Gonzalvo C; Llobera M; Pocoví M
    Eur J Endocrinol; 1999 Nov; 141(5):502-5. PubMed ID: 10576767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.
    Perron P; Brisson D; Santuré M; Blackburn P; Bergeron J; Vohl MC; Després JP; Gaudet D
    J Endocrinol Invest; 2007; 30(7):551-7. PubMed ID: 17848837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
    Ando H; Nishimura Y; Nemoto T; Takamura T; Nagai Y; Kobayashi K
    Endocr J; 2001 Feb; 48(1):113-8. PubMed ID: 11403097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.